10:18 AM EDT, 03/26/2025 (MT Newswires) -- Avalo Therapeutics ( AVTX ) said Wednesday that Michael Heffernan has been named board chairman, succeeding Garry Neil.

Neil will continue as chief executive officer and board member, the company said.

Heffernan is the founder and chairman of Collegium Pharmaceutical (COLL), where he also previously served as president and CEO, Avalo said.

Avalo shares were more than 3% higher in recent trading.

Price: 8.72, Change: +0.18, Percent Change: +2.12